Fundraising Fox
Helsinn
Lugano, CH · Founded 1976 · 343 employees on LinkedIn · 1 known investors
Find your way into Helsinn
Sign up to see every warm intro you have to Helsinn
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Helsinn team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Helsinn is a global pharmaceutical company that develops and distributes supportive care medications for patients with cancer and chronic diseases. The company operates through a combination of direct sales in the United States and commercial partnerships internationally.
Founders & leadership
RB
Riccardo BragliaChairman and CEO at HelsinnRiccardo Braglia is CEO and Chairman of Helsinn Group, a pharmaceutical company focused on late-stage licensing and distribution of supportive care medications for cancer and chronic disease patients across 140 countries. He also serves as Board Member for 3B Future Health Fund and Chairman of HAS Healthcare Advanced Synthesis/Cerbios Pharma.
Investors · 1
Frequently asked questions
- What does Helsinn do?
- Helsinn is a global pharmaceutical company that develops and distributes supportive care medications for patients with cancer and chronic diseases. The company operates through a combination of direct sales in the United States and commercial partnerships internationally.
- Who are Helsinn's investors?
- Helsinn's investors include Oberland Capital.
- Where is Helsinn headquartered?
- Helsinn is headquartered in Lugano, CH.